Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period from March 1, 2023, to March 31, 2023. The report details consolidated transactions of securities and derivatives involving the company's Board of Directors, Management, and Fiscal Council, filed in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively reports on insider trading activities and option exercises.
| Group | Transaction Type | Volume (R$) | Net Share Change |
|---|---|---|---|
| Board of Directors | Option Exercise | 2,731,232.52 | +208,332 |
| Management | Sales & Option Exercise | 9,014,163.02 (Gross) | +537,010 |
| Fiscal Council | None | 0.00 | 0 |
Material Changes
Material changes reported are limited to the following insider activities during March 2023:
- Board of Directors: Exercised options for 208,332 common shares at R$13.11 per share, increasing their total holding to 12,164,233 shares.
- Management:
- Sold a total of 49,400 common shares on the open market (via Itaú Corretora and XP Corretora) between March 6 and March 28 at prices ranging from R$13.50 to R$14.73.
- Exercised options for 587,410 common shares and 74,172 ADRs on March 30 at R$13.11 per share.
- Net result: Common share holdings increased from 2,113,444 to 2,650,454; ADR holdings increased from 447,435 to 521,607.
- Fiscal Council: No transactions occurred; holdings remained at zero.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly a regulatory disclosure of securities transactions.
Investor Verification Checklist
- Verify the total number of shares held by the Board and Management post-transaction to assess insider confidence levels.
- Confirm the exercise price (R$13.11) against the prevailing market price during the month to evaluate the economic benefit realized by insiders.
- Note that Management sold shares on the open market while simultaneously exercising options; verify if these sales were part of a pre-arranged trading plan (Rule 10b5-1 equivalent).
- Check subsequent filings for the conversion of the 74,172 ADRs exercised by Management into common shares.